Skip to main content
Clinical Trials/CTRI/2025/07/090210
CTRI/2025/07/090210
Not yet recruiting
Phase 3

Intraprocedural nasal HHHFNC versus Free Flow Oxygen for the Successful Endotracheal Intubation in Neonates: A Randomized Controlled Study

Dr Arun Soni1 site in 1 country220 target enrollmentStarted: July 20, 2025Last updated:

Overview

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Dr Arun Soni
Enrollment
220
Locations
1
Primary Endpoint
successful endotracheal intubation in first attempt heart rate more than hundred beats per minute, fall in spo2 less than twenty percent from baseline.

Overview

Brief Summary

Endotracheal intubation (ETI) is one of the most common emergency procedures performed in the neonatal intensive care unit (NICU).  As a convention before endotracheal intubation, the baby is either preoxygenated with 100% oxygen through bag and mask ventilation or free flow oxygen is administered during the procedure. The use of heated humidified high flow nasal cannula (HHHFNC) therapy has been tried to improve the success of endotracheal intubation in neonates. Recently it has been shown to decrease the intraprocedural physiological instability i.e., oxygen desaturation to <20% from baseline and bradycardia in neonates. To evaluate this, we plan to conduct this randomized control trial, where the study participants will be divided into two groups (HHHFNC group and free flow oxygen group) enrolling 110 intubations in each group, consisting of neonates of all gestational ages admitted in NICU who will be requiring endotracheal intubation. The primary outcome will be the successful endotracheal intubation, defined as endotracheal intubation in the first attempt not associated with oxygen desaturation to <20% from baseline and bradycardia (heart rate <100 bpm). The secondary outcome measures will include cumulative durations of oxygen desaturation <20% from baseline and bradycardia (hear rate <100 bpm), median heart rate and spo2 during the procedure and number of intubation attempts. We expect that using high flow oxygen compared to free flow oxygen during the procedure will increase endotracheal intubation success rate.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
0.00 Day(s) to 28.00 Day(s) (—)
Sex
All

Inclusion Criteria

  • Male and female neonates of all gestational ages.

Exclusion Criteria

  • requirement for immediate endotracheal intubation as determined by treating clinician, insufficient time for the researcher to randomize and setup study equipment, unable to achieve spo2 more than ninety percent prior to intubation, heart rate less than hundred beats per minute prior to randomization, contraindications to HFNC like congenital upper airway anomaly, congenital diaphragmatic hernia, abdominal wall defect, congenital cyanotic heart disease, failure to obtain consent.

Outcomes

Primary Outcomes

successful endotracheal intubation in first attempt heart rate more than hundred beats per minute, fall in spo2 less than twenty percent from baseline.

Time Frame: Baseline

Secondary Outcomes

  • cumulative duration of oxygen desaturation more than twenty percent from baseline, cumulative duration of bradycardia heart rate less than hundred beats per minute, number of attempts for intubation, duration of intubation attempts, adverse events during intubation, severe like esophageal intubation with delayed recognition, airway trauma, hypotension, pneumothorax, pneumomediastinum, non severe esophageal intubation with immediate recognition, mainstem bronchial intubation, oral or airway bleeding, lip trauma.(Baseline)

Investigators

Sponsor
Dr Arun Soni
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Arun Soni

Sir Ganga Ram Hospital

Study Sites (1)

Loading locations...

Similar Trials